Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences RNA-Seq, Digital PCR, and Liquid Biopsies: Capturing Value from Circulating Biomarkers

Chwee Teck Lim's Biography



Chwee Teck Lim, NUS Society Chair Professor, Acting Director, Biomedical Institute for Global Health Research and Technology, National University of Singapore

Professor Lim is NUS Society Chair Professor, Acting Director, Biomedical Institute for Global Health Research and Technology at the National University of Singapore. His research interests include the mechanobiology of human diseases and the development of microfluidic technologies for disease detection, diagnosis and therapy. He has authored more than 300 peer-reviewed papers (including 43 invited/review articles) and delivered more than 290 invited talks. He is an elected Fellow of the American Institute for Medical and Biological Engineering as well as an elected member of the World Council of Biomechanics. He currently sits on the editorial boards of 13 international journals. Prof Lim co-founded four startups which are commercializing technologies developed in his lab. He and his team have garnered more than 50 research awards and honors including the Asian Scientist 100 (2016), University’s Outstanding Researcher and Outstanding Innovator Awards (2014), the Credit Suisse Technopreneur of the Year Award, Wall Street Journal Asian Innovation Award (Gold) and the Asian Entrepreneurship Award (First Prize) (2012), President's Technology Award (2011) and the IES Prestigious Engineering Achievement Award (2010).

Chwee Teck Lim Image

Microfluidics to Enable the Single Cell Analysis of Circulating Tumor Cells for Personalized Treatment

Monday, 21 March 2016 at 09:30

Add to Calendar ▼2016-03-21 09:30:002016-03-21 10:30:00Europe/LondonMicrofluidics to Enable the Single Cell Analysis of Circulating Tumor Cells for Personalized TreatmentSELECTBIOenquiries@selectbiosciences.com

Cancer diagnosis and treatment are often hindered by the complexity of tumor heterogeneity.  Here, we developed a microfluidic biochip that is able to select any circulating tumor cell(s) of interest for downstream molecular analysis to probe their heterogeneity so as to obtain patient derived information for the personalized treatment of cancer patients.


Add to Calendar ▼2016-03-21 00:00:002016-03-22 00:00:00Europe/LondonRNA-Seq, Digital PCR, and Liquid Biopsies: Capturing Value from Circulating BiomarkersSELECTBIOenquiries@selectbiosciences.com